Relative bioavailability of artesunate and dihydroartemisinin: Investigations in the isolated perfused rat liver and in healthy Caucasian volunteers

American Journal of Tropical Medicine and Hygiene

Volumn 66, Issue 2, 2002, Pages 130-136

  Batty, Kevin T ^a   Ilett, Kenneth F ^a   Powell, Shane M ^a   Martin, Jaye ^a   Davis, Timothy M E ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; DIHYDROARTEMISININ;

ADULT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CAUCASIAN; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; COUGHING; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG COST; DRUG POTENCY; HEADACHE; HUMAN; HUMAN EXPERIMENT; LIVER PERFUSION; MALARIA; MALE; NAUSEA; NONHUMAN; NORMAL HUMAN; RAT; TINNITUS;

ANIMALIA; PROTOZOA;

EID: 0036310864     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2002.66.130     Document Type: Article

References (36)

1. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria
2. Artemisinin drugs in the treatment of malaria: From medicinal herb to registered medication
3. A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria
4. Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria
5. Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria
6. A pharmacokinetic and pharmacodynamic study of artesunate for vivax malaria
7. Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria
8. Pharmacokinetics of artemisinin and artesunate after oral administration in healthy volunteers
9. Pharmacokinetic and bioequivalence evaluation of two generic formulations of oral artesunate
10. Treatment of acute, uncomplicated, falciparum malaria with oral dihydroartemisinin
11. Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria
12. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria
13. Monotherapy with sodium artesunate for uncomplicated falciparum malaria in Thailand: A comparison of 5- and 7-day regimens
14. Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malaria
15. Comparative clinical trial of artesunate followed by mefloquine in the treatment of acute uncomplicated falciparum malaria: Two- and three-day regimens
16. Severe falciparum malaria with hyperparasitaemia treated with intravenous artesunate
17. Assessment of the effect of malaria infection on hepatic clearance of dihydroartemisinin using rat liver perfusions and microsomes
18. The isolated perfused rat liver: Conceptual and practical considerations
19. The multiple-indicator dilution technique for characterization of normal and retrograde flow in once-through rat liver perfusions
20. Selective high-performance liquid chromatographic determination of artesunate and alpha- and beta-dihydroartemisinin in patients with falciparum malaria
21. Correction of the QT interval for heart rate: Review of different formulas and the use of Bazett's formula in myocardial infarction
22. Reduction in QT dispersion by sotalol following myocardial infarction
23. Kinetics of metabolite formation and elimination in the perfused rat liver preparation: Differences between the elimination of preformed acetaminophen and acetaminophen formed from phenacetin
24. An optimized model for rat liver perfusion studies
25. The rat biliary metabolites of dihydroartemisinin, an antimalarial endoperoxide
26. Morpholinoalkyl ester prodrugs of diclofenac: Synthesis, in vitro and in vivo evaluation
27. Pharmacokinetics of the pivaloyloxyethyl (POE) ester of methyldopa, a new prodrug of methyldopa
28. Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria
29. Mechanisms of bile formation, hepatic uptake, and biliary excretion
30. Metabolism of antimalarial sesquiterpene lactones
31. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives
32. Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials
33. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males
34. Electrocardiographic monitoring in severe falciparum malaria